市場調査レポート
商品コード
1347702
ニコチンガム市場:世界の産業動向、シェア、規模、成長、機会、2023~2028年予測Nicotine Gum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ニコチンガム市場:世界の産業動向、シェア、規模、成長、機会、2023~2028年予測 |
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界のニコチンガム市場規模は2022年に15億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて4.7%の成長率(CAGR)を示し、2028年までに20億米ドルに達すると予測しています。
ニコチンガムは、店頭販売(OTC)の禁煙補助剤です。タバコ依存に悩む個人がタバコの消費を最小限に抑え、最終的には禁煙できるよう支援することを目的としています。ガムを噛むとニコチンが放出され、口の粘膜から血流に吸収されます。これにより、ニコチンへの欲求が徐々に抑えられ、禁断症状や喫煙への衝動が軽減されます。一般的に、ニコチン含有量に応じて2mg、4mg、6mgの3種類があり、1日に消費するタバコの本数に応じて使用されます。
肺がんやその他の呼吸器疾患の増加も、市場の成長を促す主な要因のひとつです。喫煙は、冠状動脈性心臓病(CHD)、脳卒中、口腔咽頭がん、食道がん、結核、関節リウマチ、免疫関連のさまざまな病気など、さまざまな慢性疾患を引き起こすことが知られています。健康志向の高まりとともに、これらの病気に対する意識が高まっていることが、市場の成長に寄与しています。さらに、禁煙療法の普及も成長を促す要因となっています。先進国・新興国を問わず、さまざまな政府および非政府組織(NGO)がニコチンガムなどの禁煙補助製品の使用を推進し、たばこ中毒の個人、特に若者を支援しています。ニコチン飴の開発など様々な製品の革新、急速な都市化、広範な研究開発活動など、その他の要因が市場をさらに牽引すると予測されます。
The global nicotine gum market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
Nicotine gum is an over the counter (OTC) smoking cessation product. It aims to assist individuals suffering from tobacco dependence in minimizing their consumption of cigarettes and eventually quit smoking. Nicotine is released when the gum is chewed and is absorbed into the bloodstream through the lining of the mouth. This aids in gradually curbing nicotine cravings and reducing the withdrawal symptoms and urge to smoke. It is commonly available in three variants: 2mg, 4mg and 6mg based on the nicotine content and is used by the individuals based on the number of cigarettes consumed by them on a daily basis.
The rising instances of lung cancer and other respiratory disorders is one of the key factors driving the growth of the market. Smoking is known to cause various chronic diseases, such as coronary heart disease (CHD), stroke, oropharyngeal cancer, esophageal cancer, tuberculosis, rheumatoid arthritis and various immunity-related ailments. The rising awareness regarding these ailments, along with the increasing health consciousness, is contributing to the market growth. Additionally, widespread adoption of smoking cessation therapies is acting as another growth-inducing factor. Various government and non-government organizations (NGOs) across both the developed and emerging nations are promoting the usage of smoking cessation products, such as nicotine gums, to assist individuals, especially the youth, with tobacco addiction. Other factors, including various product innovations such as the development of nicotine lozenges, rapid urbanization and extensive research and development activities, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nicotine gum market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and distribution channel.
Withdrawal Clinics
Medical Practice
Individual Smokers
Others
Retail Pharmacies
Specialty Stores
Online Stores
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company, etc.